Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1288/00005537-199410000-00009 http://scihub22266oqcxt.onion/10.1288/00005537-199410000-00009 7934594!ä!7934594 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Laryngoscope 1994 ; 104 (10): 1235-9 Nephropedia Template TP {{tp|p=7934594|t=1994. Immune-mediated inner ear disease and parvovirus B19 |pdf=|usr=}}{{7934594}} gab.com Text Immune-mediated inner ear disease and parvovirus B19 JO: Laryngoscope http://www.kidney.de/pget.php?&tw=1&pmid=7934594 #FOAvip Human parvovirus B19 (HP-B19), the etiologic agent of the common childhood illness erythema infectiosum, has been implicated in systemic immune disorders. Patients presenting with sensorineural hearing loss and/or dizziness, not readily categorized, were evaluated for immune-mediated inner ear disease. Appropriate serologic studies including parvovirus B19 antibody titers were conducted. Thirty patients with suspected immune-mediated inner ear disease were treated with corticosteroid trial for 5 to 7 days, then reexamined with repeat audiogram and/or vestibular testing. Seventeen patients with clinical response were treated with long-term corticosteroids and cyclophosphamide. Six patients had positive HP-B19 immunoglobulin M (IgM) titers and 8 patients had positive parvovirus immunoglobulin G (IgG) titers. All 14 patients responded to therapy. Parvovirus B19, therefore, is a possible etiology of immune-mediated inner ear disease. Twit Text FOAVip Immune-mediated inner ear disease and parvovirus B19 ????Laryngoscope http://www.kidney.de/pget.php?&tw=1&pmid=7934594 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=7934594 #FOAvip English Wikipedia <ref>{{Cite pmid|7934594}}</ref> Immune-mediated inner ear disease and parvovirus B19 #MMPMID7934594 Cotter CS; Singleton GT; Corman LC Laryngoscope 1994[Oct]; 104 (10): 1235-9 PMID7934594show ga Human parvovirus B19 (HP-B19), the etiologic agent of the common childhood illness erythema infectiosum, has been implicated in systemic immune disorders. Patients presenting with sensorineural hearing loss and/or dizziness, not readily categorized, were evaluated for immune-mediated inner ear disease. Appropriate serologic studies including parvovirus B19 antibody titers were conducted. Thirty patients with suspected immune-mediated inner ear disease were treated with corticosteroid trial for 5 to 7 days, then reexamined with repeat audiogram and/or vestibular testing. Seventeen patients with clinical response were treated with long-term corticosteroids and cyclophosphamide. Six patients had positive HP-B19 immunoglobulin M (IgM) titers and 8 patients had positive parvovirus immunoglobulin G (IgG) titers. All 14 patients responded to therapy. Parvovirus B19, therefore, is a possible etiology of immune-mediated inner ear disease. |Adrenal Cortex Hormones/therapeutic use[MESH] |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Antibodies, Viral/analysis[MESH] |Autoimmune Diseases/drug therapy/*immunology[MESH] |Child[MESH] |Child, Preschool[MESH] |Cyclophosphamide/therapeutic use[MESH] |Erythema Infectiosum/*complications/immunology[MESH] |Female[MESH] |Hearing Loss, Sensorineural/drug therapy/etiology[MESH] |Humans[MESH] |Immunosuppressive Agents/therapeutic use[MESH] |Labyrinth Diseases/drug therapy/*immunology/*virology[MESH] |Male[MESH] |Methotrexate/therapeutic use[MESH] |Middle Aged[MESH] |Parvovirus B19, Human/*immunology[MESH]Immune-mediated inner ear disease and parvovirus B19 (epmc).pdf DeepDyve Pubget Overpricing